Search research articles
Contact Us
Filters
Showing results (151-160 of 196) with videos related to
Page
of 20
Sort By:
Brain and Behavior
|
June 28, 2024
The effect of COVID-19 vaccination on multiple sclerosis activity as reflected by MRI
Esther Ganelin-Cohen, Chen Buxbaum, Noam Bosak, et al.
British Journal of Cancer
|
November 3, 2004
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma
I Hus, A Dmoszynska, J Manko, et al.
Leukemia
|
June 12, 2013
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
V S Hoffmann, M Baccarani, D Lindoerfer, et al.
Muscle & Nerve
|
March 8, 2026
Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients-A Population-Based, Matched Case-Control Study
Keshet Pardo, Tasneem Kab, Mark A Hellmann, et al.
European Journal of Haematology
|
August 22, 2003
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)
A Wrzesień-Kuś, T Robak, E Lech-Marańda, et al.
Tissue Antigens
|
February 7, 2014
IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation
E Jaskula, A Lange, D Dlubek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 18, 2024
Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter Study
Lior Fuchs, Adi Wilf-Yarkoni, Hadar Kolb, et al.
Ambio
|
November 3, 2016
Differentiating the effects of climate and land use change on European biodiversity: A scenario analysis
Jan E Vermaat, Fritz A Hellmann, Astrid J A van Teeffelen, et al.
European Journal of Haematology
|
January 26, 1999
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland
T Robak, M Błasińska-Morawiec, J Błoński, et al.
European Journal of Haematology
|
October 24, 1997
2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases
T Robak, M Błasińska-Morawiec, E Krykowski, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 196) with videos related to
Sort By:
Page
of 20
Brain and Behavior
|
June 28, 2024
The effect of COVID-19 vaccination on multiple sclerosis activity as reflected by MRI
Esther Ganelin-Cohen, Chen Buxbaum, Noam Bosak, et al.
British Journal of Cancer
|
November 3, 2004
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma
I Hus, A Dmoszynska, J Manko, et al.
Leukemia
|
June 12, 2013
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
V S Hoffmann, M Baccarani, D Lindoerfer, et al.
Muscle & Nerve
|
March 8, 2026
Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients-A Population-Based, Matched Case-Control Study
Keshet Pardo, Tasneem Kab, Mark A Hellmann, et al.
European Journal of Haematology
|
August 22, 2003
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)
A Wrzesień-Kuś, T Robak, E Lech-Marańda, et al.
Tissue Antigens
|
February 7, 2014
IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation
E Jaskula, A Lange, D Dlubek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 18, 2024
Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter Study
Lior Fuchs, Adi Wilf-Yarkoni, Hadar Kolb, et al.
Ambio
|
November 3, 2016
Differentiating the effects of climate and land use change on European biodiversity: A scenario analysis
Jan E Vermaat, Fritz A Hellmann, Astrid J A van Teeffelen, et al.
European Journal of Haematology
|
January 26, 1999
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland
T Robak, M Błasińska-Morawiec, J Błoński, et al.
European Journal of Haematology
|
October 24, 1997
2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases
T Robak, M Błasińska-Morawiec, E Krykowski, et al.
Page
of 20